Nasdaq 100 Stocks SEC Filings — May 07, 2026

07-05-2026

Optimum Communications reported Q1 2026 total revenue of $2.07 billion, down 4.0% YoY, driven by residential revenue declines of 6.5% to $1.56 billion and broadband PSU net losses of 64k, resulting in a net loss of $2,884.1 million primarily due to a $2.7 billion non-cash impairment charge. Positively, Adjusted EBITDA reached $789.0 million (-1.3% YoY) with margin expansion to 38.2% (+110 bps YoY), mobile lines achieved 52k net additions (strongest in 6 years) boosting revenue 35% to $50 million, and cash capital expenditures fell 13.6% to $307.7 million. Operational efficiencies supported gross margin expansion to 69.4% (+60 bps YoY), though net cash from operating activities declined 9.2% to $170.3 million.

• ·Consolidated net leverage 7.5x L2QA as of March 31, 2026
• ·Weighted average cost of debt 6.8%, weighted average life 3.1 years for consolidated Optimum Communications
• ·Lightpath refinanced all outstanding indebtedness via asset-backed securitization on March 3, 2026
• ·Cablevision Litchfield and CSC Optimum entered $1.1 billion incremental term loan on January 12, 2026
• ·96% of total footprint had 1 Gig or higher speeds available end Q1 2026
• ·Residential mobile penetration of broadband base 8.8% end Q1 2026 (up from 6.3% Q1 2025)

07-05-2026

Maximus reported Q2 FY2026 revenue of $1.31 billion, down 4% YoY from $1.36 billion due to the absence of prior-year natural disaster support and temporary surges, but delivered improved diluted EPS of $1.80 (up from $1.69) and adjusted diluted EPS of $2.07 (up from $2.01), with adjusted EBITDA margin expanding to 14.4% from 13.7%. Segment results were mixed: U.S. Federal revenue fell to $753 million (vs $778 million) but organic growth was 1.5% and operating margin rose to 17.6% (vs 15.3%); U.S. Services revenue declined to $416 million (vs $442 million) with operating margin at 9.3% (vs 12.2%, or 10.9% adjusted); Outside U.S. revenue dropped to $137 million (vs $142 million) and swung to a $3.1 million operating loss from a $4.8 million profit. The company raised FY2026 adjusted EBITDA margin guidance to 14.2% (+20 bps) and adjusted diluted EPS to $8.25-$8.55 (+$0.20), reiterated revenue at $5.2-$5.35 billion, and authorized a $400 million share repurchase program refresh alongside a $0.33 quarterly dividend.

• ·YTD signed contract awards $913 million; contracts pending $322 million.
• ·Sales pipeline: $4.55 billion proposals pending, $1.48 billion in preparation, $50.7 billion opportunities tracking; 59% new work.
• ·Unrestricted cash $157 million; net leverage 1.8x (target 2x-3x); DSO 78 days.
• ·Q2 cash from operations $190 million.
• ·Quarterly dividend $0.33/share payable June 1, 2026 (record May 15, 2026).
• ·FY2026 guidance: free cash flow $450-$500 million; interest expense $84 million; tax rate 24-25%.
• ·Non-cash impairment $6.9 million in U.S. Services; R&D tax benefit $4.2 million.

07-05-2026

Evommune reported first quarter 2026 financial results with cash, cash equivalents, and investments of $307.0 million as of March 31, 2026, up from $216.7 million at December 31, 2025, expected to fund operations through 2028. However, revenue fell to $0 from $3.0 million YoY, research and development expenses increased to $17.3 million from $14.4 million, general and administrative expenses rose to $6.6 million from $3.7 million, and net loss widened to $21.7 million from $14.6 million. The company highlighted pipeline progress, with Phase 2b enrollment complete for EVO756 in CSU (top-line June 2026, N=160) and AD (top-line 3Q26, N=120), plans for EVO756 migraine trial mid-2026, and EVO301 subcutaneous Phase 2b in AD mid-2027.

• ·Presentations at FOCIS (June 9-12, 2026), AHS (June 4-7, 2026), and SID (May 13-16, 2026) on MRGPRX2 and IL-18 data.
• ·EVO301 additional indications under evaluation: ulcerative colitis, cardiovascular-related inflammatory conditions, food allergy.
• ·Detailed balance sheet: Cash, cash equivalents and short-term investments $211.5M (Mar 31, 2026) vs $149.2M (Dec 31, 2025); Long-term investments $95.5M vs $67.5M.

07-05-2026

Booking Holdings Inc. executed an Officers’ Certificate on May 7, 2026, for the issuance of $750,000,000 aggregate principal amount of 5.375% Senior Notes due 2036, following an underwriting agreement dated May 5, 2026, with Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC as representatives. The Senior Notes are general senior unsecured obligations, bearing semi-annual interest at 5.375% starting November 7, 2026, and maturing on May 7, 2036, unless redeemed earlier. No period-over-period financial metrics are provided in the filing.

• ·Senior Notes are redeemable prior to February 7, 2036 (Par Call Date) at the greater of 100% of principal or present value of remaining payments discounted at Treasury Rate plus 15 basis points, plus accrued interest.
• ·Indenture includes customary events of default, with acceleration possible by Trustee or holders of 25% of outstanding principal upon non-bankruptcy defaults.
• ·Offering conducted pursuant to shelf Registration Statement (File No. 333-273678).

07-05-2026

Murphy USA Inc. issued a news release on May 7, 2026, announcing a dividend declaration with a rate increase from the previous quarter. This disclosure was made under Regulation FD as part of an 8-K filing. No specific financial metrics or comparisons were detailed in the filing body.

07-05-2026

Century Communities, Inc. held its Annual Meeting of Stockholders on May 6, 2026, with a strong quorum of 27,486,313 shares present, representing 94.7% of the 29,025,462 outstanding shares. All seven director nominees were elected with majority support (ranging from approximately 90% for John P. Box to 98% for Dale Francescon), the appointment of Ernst & Young LLP as independent auditors was ratified with 99% approval, and the advisory vote on executive compensation passed with about 88% in favor despite 3,000,529 votes against. No proposals failed, indicating robust shareholder approval across the board.

• ·Proposal 1 Director Votes - John P. Box: 23,887,907 For, 2,522,092 Against; James M. Lippman: 25,269,142 For, 1,140,857 Against
• ·Proposal 2 Auditor Ratification: 27,243,512 For, 232,820 Against, 9,981 Abstained
• ·Proposal 3 Exec Comp: 23,404,448 For, 3,000,529 Against, 13,477 Abstained

07-05-2026

Faraday Future announced plans to upgrade the FX Super One MPV to a more competitive 800V BEV or accelerate the AIHER hybrid project, pausing the original 400V cooperation and potentially delaying mass-production deliveries until strategic financing is secured. The company has shipped 68 EAI robots as of April 30, 2026, achieving positive gross margins, with May shipments accelerating toward a first-quarter target of 200 units and cumulative 2026 shipments exceeding 1,000 units, supported by $45M in recent financing. This strategic shift prioritizes robotics ramp-up to reduce near-term cash outflows and financial risk, but underscores dependency on future funding and execution challenges.

• ·Super One 800V BEV delivery timeline post-funding: first phase 6-9 months, second 12-15 months, third 21-24 months
• ·AIHER hybrid delivery timeline post-funding: first phase 9-12 months, second 21-24 months, third 24-28 months
• ·Press release dated May 5, 2026; SEC filing May 7, 2026

07-05-2026

For the three months ended March 31, 2026, Invesco CurrencyShares Canadian Dollar Trust reported total assets of $84,074,863, up 12.2% from $74,931,453 at December 31, 2025, driven by net share purchases of 150,000 shares adding $10,701,981 to redeemable capital shares, reaching 1,200,000 shares outstanding valued at $84,046,301. However, interest income declined 45.0% YoY to $103,924 from $189,029, leading to net comprehensive income of $23,508, down 81.7% YoY from $122,723, with sponsor's fees rising 21.3% to $80,416. Shares outstanding increased, but earnings per share fell to $0.02 from $0.12 YoY.

• ·Net cash provided by operating activities $22,858 in Q1 2026 vs $142,646 in Q1 2025.
• ·Net cash provided by financing activities $10,644,864 in Q1 2026 vs $6,757,702 in Q1 2025.
• ·Effect of exchange rate on cash $(1,527,180) in Q1 2026 vs $(154,441) in Q1 2025.
• ·Distributions $(23,089) in Q1 2026 vs $(142,552) in Q1 2025.

07-05-2026

For Q1 2026, Invesco DB Base Metals Fund reported total assets of $298.7M and shareholders' equity of $290.8M, up 47% and 44% QoQ respectively from $202.8M and $202.5M at year-end 2025, driven by net share purchases of 3.55M shares increasing outstanding shares to 12.4M; NAV per share rose 2.5% QoQ to $23.45. However, net income declined 76% YoY to $0.5M from $2.1M in Q1 2025, due to a $14.8M unrealized loss on commodity futures contracts offsetting $13.5M realized gains.

• ·Unrealized depreciation on LME Commodity Futures Contracts: $4.3M as of March 31, 2026 (up from $0.2M at Dec 31, 2025)
• ·Net realized gain on Commodity Futures Contracts Q1 2026: $13.5M (vs loss of $0.1M in Q1 2025)
• ·Net change in unrealized loss on Commodity Futures Contracts Q1 2026: -$14.8M (vs gain of $1.2M in Q1 2025)
• ·Total notional value of open commodity futures contracts: $290.8M as of March 31, 2026

07-05-2026

ACADIA Pharmaceuticals reported Q1 2026 total revenues of $268,062 thousand, up 9.7% YoY from $244,317 thousand, driven by strong 19.5% growth in DAYBUE to $101,138 thousand while NUPLAZID increased modestly 4.5% to $166,924 thousand. However, SG&A expenses surged 35.3% to $171,019 thousand, resulting in an operating loss of $4,616 thousand versus $19,290 thousand profit YoY and net income declining 80.8% to $3,637 thousand. Cash and cash equivalents rose to $282,212 thousand from $177,695 thousand at December 31, 2025, with net cash from operations at $33,981 thousand, up from $20,323 thousand YoY.

• ·Net cash provided by operating activities $33,981 thousand in Q1 2026, up from $20,323 thousand YoY.
• ·Investment securities decreased to $569,246 thousand at March 31, 2026 from $641,991 thousand at December 31, 2025.
• ·R&D expenses slightly declined 1.8% YoY to $76,868 thousand.
• ·Weighted average diluted shares outstanding 172,706 thousand in Q1 2026.

07-05-2026

For the quarter ended March 31, 2026, Invesco DB Precious Metals Fund reported total assets of $279.2M, up 8.3% from $257.7M at December 31, 2025, with shareholders' equity rising 8.4% to $279.0M and NAV per share increasing 6.2% to $109.41. Total income grew 46% YoY to $2.5M, driven by higher interest and dividends, and net realized gains on futures surged over 1,100% YoY to $3.7M; however, net income declined 44% YoY to $15.2M due to a 63% drop in unrealized gains on commodity futures contracts to $9.5M.

• ·Shares outstanding increased by 50,000 (2%) QoQ to 2,550,000 due to net purchases of $6.2M.
• ·Open long futures contracts: 440 COMEX Gold (notional $210.3M), 161 COMEX Platinum (notional $16.0M), 137 COMEX Silver (notional $52.6M).
• ·Net cash from operating activities: -$6.2M in Q1 2026 (vs -$20.0M in Q1 2025), offset by $6.2M from financing.

07-05-2026

Madison Square Garden Entertainment Corp. reported fiscal 2026 Q3 revenues of $246.3 million, up 2% YoY to $242.5 million, driven by 3% growth in entertainment offerings from more concerts at The Garden and higher Christmas Spectacular revenues. However, operating income declined 41% to $16.1 million and adjusted operating income fell 20% to $46.0 million due to higher direct operating expenses, SG&A up 17%, and restructuring charges, while food/beverage/merchandise revenues dipped 2%. For the nine months ended March 31, 2026, revenues rose 10% to $864.5 million with adjusted operating income up 9% to $243.5 million.

• ·Q3 FY2026 direct operating expenses for entertainment offerings, arena license fees and other leasing increased 10% to $118.3 million.
• ·Q3 FY2026 food, beverage and merchandise direct operating expenses decreased 8% to $28.5 million.
• ·Q3 FY2026 SG&A expenses increased 17% to $61.0 million due to higher employee compensation, rent, and other costs.
• ·Fewer Knicks and Rangers games (combined five fewer) at The Garden impacted arena license fees (down 3%) and F&B sales.
• ·Revenues from other live entertainment and sporting events decreased $7.7 million due to fewer events including absence of a prior-year multi-day special event at Radio City Music Hall.
• ·Q3 FY2026 net income $5.1 million ($0.11/share) vs. $8.0 million ($0.17/share) prior year.
• ·9M FY2026 operating income up 2% to $150.2 million.
• ·Restructuring charges of $8.6 million in Q3 FY2026.

07-05-2026

NexMetals Mining Corp. issued a news release on May 7, 2026, reporting assay results from its surface drilling program at the Selebi Mines Project in Botswana, furnished under Item 7.01 Regulation FD Disclosure. The filing includes cautionary statements on mineral resources under NI 43-101 and S-K 1300, noting uncertainties in indicated and inferred resources and that they should not be assumed economically mineable. No specific assay results, financial metrics, or period comparisons are detailed in the filing.

• ·Filing incorporates Canadian NI 43-101 standards and notes alignment/differences with SEC S-K 1300 mining disclosure rules.
• ·Company address: 1111 West Hastings Street, 15th Floor, Vancouver, British Columbia, Canada V6E 2J3; Phone: (604) 770-4334.
• ·Common Shares trade as NEXM on Nasdaq Capital Market.

07-05-2026

ImmunityBio reported record Q1 2026 net product revenue of $44.2 million, up 168% YoY from $16.5 million and 15% QoQ from Q4 2025's $38.3 million, driven by strong ANKTIVA sales momentum and unit growth. However, net loss widened dramatically to $632.8 million from $129.6 million YoY, primarily due to $530.9 million in non-cash fair value changes on liabilities amid rising stock price, with R&D expenses up $19.8 million to $68.0 million and SG&A up $13.1 million to $45.8 million. Cash position strengthened to $380.9 million as of March 31, 2026, from $242.8 million at year-end 2025.

• ·ANKTIVA approved or authorized in five jurisdictions covering ~34 countries, including first Asia approval in Macau.
• ·NCCN guidelines updated to Category 2A recommendation for ANKTIVA plus BCG in BCG-unresponsive NMIBC papillary-only disease.
• ·QUILT-2.005 BCG-Naïve CIS trial fully enrolled; IDMC confirms no additional enrollment needed; sBLA on track for 2026.
• ·Adjusted net loss $86.2 million in Q1 2026 vs $82.7 million Q1 2025.
• ·Net cash used in operating activities $75.4 million in Q1 2026, improved from $85.9 million Q1 2025.

07-05-2026

Paradigm, Strategies in Wealth Management, LLC disclosed total holdings of $147,407,415 across 55 positions in its 13F-HR filing as of March 31, 2026. The portfolio is diversified with significant allocations to ETFs such as Schwab Strategic TR US Dividend Equity ($19,629,995), Schwab Strategic TR US LCAP GR ETF ($19,062,171), and iShares TR Core S&P SCP ETF ($16,231,740), alongside individual stocks like Apple Inc. ($3,701,913 for 14,587 shares) and Procter & Gamble Co. ($3,786,435 for 26,215 shares). No changes in holdings were indicated.

• ·Report period end date: 03-31-2026
• ·Filing date: 05-07-2026
• ·All holdings reported as sole discretionary voting power (SH SOLE)
• ·Filer CIK: 0001859579
• ·State of incorporation: MN

07-05-2026

This DEF 14A proxy statement solicits votes from shareholders of John Hancock CQS Multi Asset Credit Fund and affiliated funds for the election of three trustees at a special joint meeting on June 18, 2026; all shareholders vote on this routine proposal with no expected material changes to fund operations. Shareholders of the John Hancock Marathon Asset-Based Lending Fund are additionally asked to approve a new subadvisory agreement with Marathon Asset Management, LP, required due to its acquisition by CVC Capital Partners affiliates in January 2026, ensuring management continuity without changes to the portfolio team. The Board unanimously recommends voting 'FOR' both proposals.

• ·Record date for shareholders entitled to vote: March 23, 2026
• ·Meeting location: 200 Berkeley Street, Boston, Massachusetts 02116 at 2:00 P.M. Eastern Time on June 18, 2026
• ·Fiscal year end: October 31
• ·Marathon name change date: January 18, 2024
• ·No fee required for filing; payment of filing fee checked as 'No fee required'

07-05-2026

Northwestern Mutual Wealth Management Co filed its 13F-HR on May 07, 2026, disclosing 4,113 equity holdings as of March 31, 2026, managed across multiple sub-advisers in a combination report. The portfolio features massive positions including Advanced Micro Devices at $130,086,610,000, AbbVie at $59,272,384,000, and Akamai Technologies at $40,747,516,000, reflecting broad exposure to technology, healthcare, and ETFs. No prior period data or changes are detailed in this routine quarterly snapshot.

• ·Filing covers period ending 2026-03-31
• ·13F combination report including sub-advisers such as BlackRock Investment Management, LLC, AllianceBernstein L.P., and others

07-05-2026

Intellus Advisors LLC filed its 13F-HR on May 7, 2026, disclosing $731,807,044 in total holdings across 125 positions as of March 31, 2026, all held solely. Top positions include Invesco QQQ Trust ($72,192,108), iShares Gold Trust ($50,817,364), Vanguard Dividend Appreciation ETF ($47,989,985), and American Century Quality Diversified International ETF ($47,416,486), reflecting a diversified mix of equity ETFs, tech stocks, and precious metals exposure. No period-over-period changes are provided in this snapshot filing.

• ·All 125 positions held as sole discretionary (SH SOLE).
• ·Address: 8889 Pelican Bay Blvd. N., Suite 102, Naples, FL 34108.
• ·SEC file number: 028-24900.
• ·Smaller positions include MiMedx Group Incorporated (18,100 shares, $71,495) and Precigen Incorporated (15,870 shares, $61,417).

07-05-2026

Mullooly Asset Management, Inc., a New Jersey-based investment manager, filed its 13F-HR report on May 07, 2026, disclosing $270,964,932 in equity holdings as of March 31, 2026, across 51 positions held with sole voting power. The portfolio is diversified with significant allocations to iShares and Vanguard ETFs (e.g., iShares Core S&P Mid-Cap ETF valued at $28,128,617 and Vanguard Total Stock Market ETF at $23,777,156), as well as individual stocks like Alphabet, Apple, and Amazon. No changes in holdings or performance metrics were detailed in the filing.

• ·Filed as of date: May 07, 2026
• ·Conformed period of report: March 31, 2026
• ·SEC file number: 028-25551
• ·Business address: 1971 State Route 34, Suite 102, Wall Township, NJ 07719

07-05-2026

Chemung Financial Corp reported Q1 2026 net income of $9.2 million, up 53% YoY from $6.0 million, driven by 19% higher net interest income to $23.6 million and a lower provision for credit losses at $0.6 million versus $1.1 million. However, non-interest expenses rose 3% to $17.5 million, comprehensive income declined to $9.5 million from $14.2 million due to lower unrealized gains on AFS securities, and total interest expense on borrowed funds increased to $1.5 million from $0.7 million YoY. Total assets grew 1% QoQ to $2.75 billion, with loans up 2% to $2.29 billion net and deposits up 2% to $2.31 billion.

• ·Basic and diluted EPS $1.91 in Q1 2026 vs $1.26 in Q1 2025.
• ·Cash dividends declared $0.34 per share in Q1 2026 vs $0.32 in Q1 2025.
• ·Treasury stock shares reduced to 491,250 at March 31, 2026 from 519,079 at Dec 31, 2025.

07-05-2026

AvalonBay Communities reported total revenue of $770,279 for Q1 2026, up 3.3% YoY from $745,880, with net income attributable to common stockholders surging 37.6% YoY to $325,730, primarily driven by a $179,912 gain on sale of communities versus $56,469 prior year. However, total expenses increased 9.1% YoY to $623,233, including higher interest expense of $71,489 (up 19.4%), property taxes up 10.1% to $90,109, and a $4,619 casualty and impairment loss; stockholders' equity declined 1.0% QoQ to $11,490,925 amid $198,480 in common stock repurchases. Operating cash flow edged up 0.7% YoQ to $418,933 but total assets dipped 0.3% QoQ to $22,126,953.

• ·Weighted average common shares - basic decreased to 139,549,709 from 142,113,283 YoY due to repurchases.
• ·Unsecured debt, net stable at approximately $7.9B.
• ·Development/redevelopment spending increased to $336,820 from $237,282 YoY.
• ·Proceeds from sale of real estate $330,378 in Q1 2026.

07-05-2026

Gladius Capital Management LP filed its 13F-HR disclosing $2,244,974,915 in total holdings as of March 31, 2026, across 106 positions primarily consisting of call and put options on major technology, semiconductor, and blue-chip stocks such as NVIDIA, Apple, Amazon, Alphabet, and Microsoft, alongside smaller common share positions and some SPAC holdings. The portfolio shows heavy emphasis on derivatives with notable concentrations in NVIDIA (789,600 call shares and 795,900 put shares), Apple (464,600 call shares and 472,100 put shares), and Amazon (313,800 call shares and 374,000 put shares), but no period-over-period changes are provided in this snapshot filing.

• ·Portfolio includes SPAC holdings such as ACTIVATE ENERGY ACQUISIT (20,000 shares), CHENGHE ACQUISITION III (15,000 shares), and SPACE ASSET ACQUISITION (20,000 shares).
• ·Largest put position: ISHARES TR PUT with 1,000,000 shares valued at $86,690,000.
• ·All positions reported as SOLE ownership with no shared voting or investment discretion.

07-05-2026

Muzinich Corporate Lending Income Fund, Inc. sold 4,893.5171 shares of its common stock on April 1, 2026, for an aggregate offering price of $5,000,000 at a per share purchase price of $1,021.76 pursuant to subscription agreements with investors. The issuance is exempt from Securities Act registration under Section 4(a)(2), Rule 506 of Regulation D for U.S. accredited investors, and Regulation S outside the U.S. This 8-K/A amends the original filing on April 2, 2026, to disclose the final pricing and share count.

• ·Sales made solely to accredited investors as defined in Rule 501(a) of Regulation D.
• ·Subscription requests required at least five business days prior to closing.

07-05-2026

07-05-2026

Warner Music Group reported Q2 FY2026 total revenue of $1,732 million, up 17% YoY (12% constant currency), driven by 17% growth in Recorded Music revenue to $1,380 million and 14% in Music Publishing to $353 million, with streaming revenue accelerating across both segments. Operating income surged 57% to $264 million, Adjusted OIBDA rose 31% to $397 million (margin up 250 bps to 22.9%), and net income jumped to $181 million from $36 million. However, Recorded Music licensing revenue declined 1% to $104 million, Music Publishing synchronization revenue grew only 2% to $50 million, and results were negatively impacted by $6 million from the BMG termination.

• ·Six months revenue $3,572M, up 13% YoY to $3,150M.
• ·Cash provided by operating activities up 83% to $126M in Q2.
• ·Free Cash Flow up to $99M from $33M in Q2.
• ·Recorded Music artist services and expanded-rights revenue up 40% to $164M.
• ·Music Publishing digital revenue up 19% to $224M.
• ·Tempo Music subsidiary debt $303M, Beethoven JV loans $370M, both nonrecourse.

07-05-2026

Gilead Sciences reported Q1 2026 total revenues up 4% YoY to $7.0 billion, driven by 8% growth in product sales excluding Veklury to $6.8 billion, 10% HIV sales growth to $5.0 billion (Biktarvy +7% to $3.4 billion, Descovy +38% to $807 million), and strong gains in Trodelvy (+37% to $402 million) and Livdelzi; however, Veklury sales fell 52% to $144 million, Cell Therapy declined 12% to $407 million (Yescarta -14%, Tecartus -4%), and Liver Disease was up only 1% to $767 million amid HCV weakness. Non-GAAP diluted EPS rose to $2.03 from $1.81, cash stood at $8.6 billion, and FY2026 product sales guidance was raised to $30.0-30.4 billion, though EPS guidance was cut due to $11.5 billion in anticipated IPR&D charges from acquisitions including completed Arcellx deal ($7.8 billion).

• ·Non-GAAP diluted EPS $2.03 in Q1 2026 vs $1.81 in Q1 2025.
• ·R&D expenses flat at $1.4 billion YoY; Non-GAAP R&D up to $1.4 billion from $1.3 billion.
• ·SG&A expenses $1.5 billion (GAAP) vs $1.3 billion YoY; Non-GAAP $1.4 billion vs $1.2 billion.
• ·Acquired IPR&D expenses $107 million, including $80 million upfront to Genhouse.
• ·FY2026 product sales ex-Veklury guidance $29.4-29.8 billion (raised); Veklury $600 million (unchanged).
• ·Board declared Q2 2026 dividend of $0.82 per share, payable June 29, 2026.
• ·PDUFA dates: BIC/LEN August 27, 2026; anito-cel December 23, 2026.

07-05-2026

The Federal Home Loan Bank of San Francisco reported under Item 2.03 the commitment to issue three consolidated obligation bonds as primary obligor, with total par value of $47 million. These include a $20M bond maturing May 5, 2031 at 4.500%, a $10M bond maturing May 14, 2031 at 4.210%, and a $17M bond maturing May 12, 2028 at 4.110%, all with Optional Principal Redemption (Bermudan style) and fixed constant rates. This routine funding activity via capital markets excludes short-term discount notes and does not reflect overall outstanding obligations.

• ·Bonds are joint and several obligations of the eleven Federal Home Loan Banks, backed only by their financial resources, not U.S. government guaranteed.
• ·Schedule A excludes discount notes with maturity of one year or less issued in ordinary course.
• ·Event date: May 4, 2026; Filing date: May 7, 2026.
• ·All bonds have Next Pay Dates in November 2026 and are Fixed Constant rate with Bermudan call style.

07-05-2026

Community Healthcare Trust Incorporated (CHCT) held its Annual Meeting of Stockholders on May 7, 2026, with 25,222,430 shares present, representing 88.27% of outstanding shares. Shareholders elected all six director nominees, approved executive compensation on an advisory basis (with 19,974,722 votes for versus 1,857,467 against), selected annual frequency for future say-on-pay votes, and ratified BDO USA, P.C. as independent auditors for 2026 with near-unanimous support (24,969,760 for versus 207,990 against). All proposals passed decisively with no significant opposition.

• ·Director election votes: Cathrine Cotman (21,559,321 For, 363,776 Withheld); David Dupuy (21,602,402 For, 320,695 Withheld); Alan Gardner (21,374,647 For, 548,450 Withheld); Claire Gulmi (21,254,283 For, 668,814 Withheld); Robert Hensley (21,266,801 For, 656,296 Withheld); Lawrence Van Horn (21,050,312 For, 872,785 Withheld).
• ·Say-on-pay frequency: Every 2 Years (20,914 votes), Every 3 Years (421,980 votes), Abstain (65,618 votes).
• ·Auditor ratification abstentions: 44,680.

07-05-2026

Cottonwood Communities, Inc. sold 214,833 shares of Series A Convertible Preferred Stock for aggregate proceeds of $2,116,000 during the period from April 29, 2026, through May 6, 2026, as part of its ongoing best-efforts private placement offering with a maximum of $200,000,000 launched on September 19, 2023. In connection with these sales, the company paid $105,960 in selling commissions and $60,330 in placement fees. As of May 6, 2026, 12,448,893 shares of Series A Convertible Preferred Stock were outstanding.

• ·Private Offering launched September 19, 2023, exempt under Rule 506(b) of Regulation D, at $10.00 per share to accredited investors without general solicitation.
• ·Date of earliest event reported: May 1, 2026; Filing date: May 7, 2026.

07-05-2026

Genco Shipping & Trading Limited (NYSE: GNK) filed definitive proxy materials (DEFA14A) on May 7, 2026, for its 2026 Annual Meeting on June 18, 2026, urging shareholders to vote 'FOR' its six director nominees on the WHITE proxy card and 'WITHHOLD' on rival Diana Shipping Inc.'s nominees amid an ongoing proxy contest and takeover attempt. The company touts its Comprehensive Value Strategy, delivering 197% TSR since April 2021, $310M in dividends ($7.16/share) over five years, 27 consecutive quarterly dividends, Q1 2026 dividend up 133% YoY, and projected Q2 dividend of $0.70/share (367% YoY increase) for a full-year 2026 total of $2.50/share. However, Diana's lowball takeover bid lacks a control premium, threatening future dividends and shareholder value.

• ·Shareholder record date: April 28, 2026.
• ·Proxy fight resources: www.GencoDrivesSuperiorReturns.com.
• ·Investor relations website: https://investors.gencoshipping.com/.
• ·Definitive proxy on Schedule 14A filed May 7, 2026.

07-05-2026

Automatic Data Processing, Inc. executed an Underwriting Agreement on May 4, 2026, with BNP Paribas Securities Corp., BofA Securities, Inc., and J.P. Morgan Securities LLC as representatives of the underwriters to issue and sell $1,000,000,000 aggregate principal amount of 5.000% senior notes due 2036. The notes were issued on May 7, 2026, under an indenture with U.S. Bank Trust Company, National Association as trustee, registered on Form S-3 (File No. 333-281920). A legal opinion on the notes' legality was provided by Davis Polk & Wardwell LLP.

• ·Underwriting Agreement dated May 4, 2026 (Exhibit 1.1)
• ·Fifth Supplemental Indenture (Exhibit 4.1)
• ·Prospectus supplement dated May 4, 2026; base prospectus dated September 4, 2024
• ·Registration Statement on Form S-3 (File No. 333-281920)

07-05-2026

Mario J. Gabelli, Trustee, Chairman, and Chief Investment Officer of The Gabelli Multimedia Trust Inc., remains absent following a medical incident on March 19, 2026, with his condition improving but return timeline undetermined. GAMCO Investors, Inc. activated its long-standing succession plan on March 22, 2026, naming Christopher J. Marangi as President; day-to-day operations continue under co-CEO Douglas R. Jamieson and Marangi, while Co-CIOs Kevin V. Dreyer and Marangi lead the Fund's portfolio management team.

• ·GAMCO previously announced Mr. Gabelli's hospitalization on March 23, 2026.
• ·Registrant address: One Corporate Center, Rye, New York 10580.
• ·Telephone: (800) 422-3554.

07-05-2026

Texas Community Bancshares reported net income of $836 thousand for the three months ended March 31, 2026, up 30% YoY from $643 thousand, supported by 3% higher net interest income to $3,431 thousand and 51% growth in noninterest income to $698 thousand, alongside a sharp drop in provision for credit losses to $6 thousand. However, total interest income declined 1% YoY to $5,570 thousand, noninterest expenses rose 8% to $3,168 thousand, and comprehensive income fell to $527 thousand due to $309 thousand after-tax losses on securities. Total assets edged up 0.1% QoQ to $430,446 thousand, with deposits increasing $4,053 thousand QoQ, while loans decreased $4,523 thousand QoQ.

• ·EPS basic $0.32 in Q1 2026 vs $0.22 in Q1 2025
• ·Cash dividend declared $0.05 per share in Q1 2026 (vs $0.04 in Q1 2025)
• ·Allowance for credit losses on loans $3,437 thousand at Mar 31 2026 (vs $3,440 thousand at Dec 31 2025)

07-05-2026

Acadian Asset Management Inc. reported total revenue of $167.0M for the three months ended March 31, 2026, up 39% YoY from $119.9M, driven by management fees increasing 41% to $159.3M. However, compensation and benefits expenses surged 58% to $96.0M, contributing to total operating expenses rising 42% to $125.1M, while operating cash flows remained negative at -$44.9M, an improvement from -$48.8M YoY. Net income attributable to controlling interests grew 21% to $24.3M with EPS of $0.68, and total assets expanded 6% QoQ to $715.4M amid new revolving credit facility drawdown of $85.0M.

• ·Performance fees increased 7.5% YoY to $5.7M.
• ·Revolving credit facility balance of $85.0M as of March 31, 2026 (previously $0).
• ·Common stock repurchases of $4.7M in Q1 2026.
• ·Dividends paid $3.6M in Q1 2026 ($0.10 per share).
• ·Net cash increase of $25.6M in Q1 2026.

07-05-2026

Saga Communications, Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.25 per share on Class A Common Stock. The dividend will be paid on June 12, 2026, to shareholders of record on May 22, 2026.

• ·Board declaration date: May 7, 2026
• ·Shareholders of record date: May 22, 2026
• ·Dividend payment date: June 12, 2026

07-05-2026

First Community Corporation's Board of Directors approved a share repurchase plan authorizing up to $7.5 million to buy back common stock, representing approximately 3.4% of total shareholders’ equity as of March 31, 2026. Repurchases may occur through May 5, 2027, via open market purchases or privately negotiated transactions at management's discretion, subject to market conditions and regulatory requirements. The plan signals confidence in capital management but is not obligatory and can be suspended or terminated at any time.

• ·Common stock trades on The Nasdaq Capital Market under symbol FCCO
• ·Repurchase plan effective through May 5, 2027, and may be discontinued, suspended, or restarted at any time

07-05-2026

Camden National Corp reported net income of $21.9 million for Q1 2026, up 199% YoY from $7.3 million in Q1 2025, driven by higher net interest income (+7%) to $52.4 million, sharply lower provision for credit losses ($0.6 million vs $9.4 million), and reduced non-interest expenses ($35.7 million vs $44.5 million, excluding prior merger costs). However, total assets declined 0.2% QoQ to $6.96 billion, net loans were flat down 0.05% QoQ at $4.92 billion, and other comprehensive loss of $0.2 million contrasted with a $12.4 million gain YoY. Deposits grew 0.9% QoQ to $5.59 billion, and shareholders' equity rose 1.9% QoQ to $710 million.

• ·Basic and diluted EPS $1.29 in Q1 2026 vs $0.43 in Q1 2025
• ·Cash dividends declared $0.42 per share in both Q1 2026 and Q1 2025
• ·Common stock repurchased: 33,131 shares for $1.5 million in Q1 2026
• ·Net cash provided by operating activities $20.0 million in Q1 2026 vs $1.0 million in Q1 2025

07-05-2026

Trilogy Metals Inc. issued a press release on May 7, 2026, welcoming the U.S. Department of the Interior’s decision to transfer approximately 1.4 million acres of federal land within Alaska’s Dalton Utility Corridor to the State of Alaska. The press release is furnished under Item 7.01 and attached as Exhibit 99.1. No financial metrics or period comparisons are provided.

• ·Filing Type: 8-K dated May 7, 2026
• ·Items reported: 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)
• ·Securities: Common Shares (TMQ) on NYSE American and Toronto Stock Exchange

07-05-2026

Radian Group reported Q1 2026 net income from continuing operations of $129 million ($0.93 per diluted share), down from $152 million ($1.03 per share) YoY due to $49 million in acquisition-related expenses from the completed Inigo acquisition, while adjusted pretax operating income rose 15% YoY to $232 million with adjusted operating EPS up 22% to $1.27. Book value per share grew 10% YoY to $35.67, Mortgage NIW increased 42% YoY to $13,490 million, but Mortgage combined ratio worsened to 30.2% from 27.8% YoY and holding company liquidity fell to $391 million from $834 million YoY. The company repurchased $50 million in shares and paid $35 million in dividends.

• ·Radian Guaranty expects to pay over $600 million in ordinary dividends during 2026.
• ·Available Assets under PMIERs $5,445 million with excess $1,596 million as of Mar 31 2026.
• ·Wind down of Mortgage Conduit business; divestiture of Title and Real Estate Services expected by Q3 2026 end.
• ·Drew $200 million on credit facility in Jan 2026, repaid $50 million in Q1.

07-05-2026

First Northern Community Bancorp reported net income of $5,906 thousand for the three months ended March 31, 2026, up 61% YoY from $3,671 thousand, supported by net interest income growth of 8% to $17,204 thousand and a reduced provision for credit losses to $300 thousand. Total assets increased 0.7% QoQ to $1,924,548 thousand, with loans up 1.3% to $1,064,622 thousand net and deposits up 0.9% to $1,694,698 thousand. However, cash and cash equivalents declined $5,970 thousand QoQ to $139,584 thousand, non-interest expenses remained elevated with salaries up 3% YoY, and accumulated other comprehensive loss widened to $(18,556) thousand due to $3,078 thousand unrealized holding losses on securities.

• ·Basic earnings per common share $0.37 vs $0.22 YoY
• ·Diluted earnings per common share $0.36 vs $0.22 YoY
• ·Allowance for credit losses $14,803 at March 31, 2026 vs $14,519 at Dec 31, 2025
• ·Investment securities AFS fair value $623,282 thousand at March 31, 2026 with unrealized losses of $28,173 thousand

07-05-2026

Mutual of America Capital Management LLC filed its Form 13F-HR on May 07, 2026, disclosing equity holdings totaling 9091852907 USD as of March 31, 2026, all held with sole voting and disposition power. Top positions include Mueller Industries (20186209 USD), Taylor Morrison Home Corp (13298813 USD), Crown Holdings (12964130 USD), RLI Corp (11421633 USD), and Tenet Healthcare (11204656 USD). No put/call options or shared power positions were reported.

• ·Report period end date: 2026-03-31
• ·All positions held as SH SOLE with no shared voting/disposition power, puts, or calls
• ·SEC file number: 028-04274